Efficacy and Safety of Docetaxel Plus Oxaliplatin as First-line Chemotherapy in Patients with Advanced or Metastatic Non-small-cell Lung Cancer
분야
의약학 > 내과학
저자
반희정 , 강현욱 , 김우진 , 박찬우 , 오인재 , 권용수 , 김규식 , 김유일 , 임성철 , 김영철
발행기관
대한결핵 및 호흡기학회
간행물정보
대한결핵및호흡기학회 추계학술발표초록집 2012년, 제114권 144(총1페이지)
파일형식
0y909795.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    1,000원
    적립금
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    Backgrounds: Platinum-based doublets are recommended as first-line treatment of stage IV non-small-cell lung cancer (NSCLC). Oxaliplatin is more potent than cisplatin, requiring fewer DNA adducts to provide equivalent cytotoxicity. The objective of this study is to evaluate the efficacy and safety of oxaliplatin combined with docetaxel as a first line treatment of stage IV NSCLC. Methods: This is prospective, single-center, phase II trial. Patients with chemotherapy-naive NSCLC received docetaxel 60 mg/m2 (day 1) and oxaliplatin 70 mg/m2 (day 2) every 3 weeks for up to 6 cycles. The primary endpoint was objective response rate (ORR) and the secondary endpoints were progression-free survival (PFS), overall survival (OS) and safety. Treatment response was evaluated according to version 1.1 of Response Evaluation Criteria in Solid Tumors. Results: For this preliminary analysis, 33 patients were enrolled and response evaluation was possible in 31. In response evaluable patients, there were no complete response, 10 partial response, 17 stable disease. ORR was 30.3% and disease control rate was 81.8%. Median PFS was 127 days (95% confidence interval, 59-195) and median OS was 394 days (95% confidence interval, 264-524). Grade 3-4 toxicities occurred in 45% of patients, and the most common hematologic toxicity was neutropenia. There were two cases of hyperglycemia and sepsis. Conclusions: This study suggests that the combination of oxaliplatin and docetaxel is effective in patients with NSCLC, with reasonable toxicities.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.